Teva’s Tushar Shah Joins Liquidia as Chief Medical Officer

Liquidia Technologies (NASDAQ: [[ticker:LQDA]]) has appointed Tushar Shah to serve in the newly created role of chief medical officer. Shah is joining Research Triangle Park, NC-based Liquidia from Teva Pharmaceutical (NYSE: [[ticker:TEVA]]), where he was head of global specialty clinical development. Liquidia develops drugs using proprietary nanoparticle technology intended to improve the delivery of medicines. The company is currently awaiting an FDA decision for LIQ861, an inhaled treatment for pulmonary arterial hypertension.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.